Trials / Conditions / Pathological Gambling

Pathological Gambling

41 registered clinical trials studyying Pathological Gambling — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Theory-based Intervention for Promoting Responsible Gambling Among College Students NCT06642155	University of Nevada, Las Vegas	N/A
Unknown	Efficacy of an Internet-based Psychological Intervention for Problem Gambling and Gambling Disorder NCT04074681	Universitat Jaume I	N/A
Completed	Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling NCT05051085	Anna Westh Stenbro	N/A
Completed	Treatment Study for Problematic Gaming and Gambling NCT05506384	Region Skane	N/A
Completed	Mental Health, Addictions and Biomarkers in High Athletes Performance NCT04842461	Cardenal Herrera University	—
Unknown	Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder NCT03464838	University of East London	N/A
Unknown	Cognitive Control Training in Online Problem Gambling NCT03673800	Assistance Publique - Hôpitaux de Paris	N/A
Unknown	Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder NCT03430180	Finnish Institute for Health and Welfare	Phase 2
Completed	Poker, Skills and Associated Problems NCT02590211	Nantes University Hospital	N/A
Completed	Milk Thistle in Pathological Gambling NCT02337634	University of Chicago	Phase 2
Completed	Dopamine Responsivity in Gamblers NCT02772978	University of California, San Francisco	N/A
Unknown	The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers NCT02491996	Kurihama Medical and Addiction Center	N/A
Completed	Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment NCT01743092	Centre for Addiction and Mental Health	N/A
Terminated	Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospectiv NCT01560351	Nantes University Hospital	N/A
Unknown	Effectiveness of Therapy Treatment NCT01596478	Problem Gambling Institute of Ontario	N/A
Withdrawn	Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling NCT01340274	Colchester East Hants Health Authority	Phase 2
Completed	Integrative Couple Treatment for Pathological Gambling NCT02240485	Université du Québec à Trois-Rivières	N/A
Completed	Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention NCT01528007	Finnish Institute for Health and Welfare	Phase 4
Completed	Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble NCT01215357	Emalex Biosciences Inc.	Phase 2
Unknown	Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling NCT01154712	BeerYaakov Mental Health Center	Phase 1
Completed	D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement NCT02203786	Centre for Addiction and Mental Health	Phase 2
Completed	Cognitive-Motivational Behavior Therapy for Pathological Gamblers NCT01135264	New York State Psychiatric Institute	N/A
Completed	Tolcapone Treatment of Pathological Gambling NCT00927563	University of Chicago	Phase 2
Completed	Topiramate Trial for Pathological Gamblers NCT01843699	University of Sao Paulo	Phase 2
Completed	Investigation of Naltrexone for Pathological Gambling NCT01057862	Yale University	Phase 2
Completed	Susceptibility to Pathological Gambling NCT01528982	University of Chicago	N/A
Completed	A Pilot SMART Design for Pathological Gamblers NCT00685724	UConn Health	N/A
Completed	Memantine Treatment Study of Pathological Gambling NCT00585169	Yale University	Phase 2
Completed	Acamprosate in the Treatment of Pathological Gambling NCT00571103	University of Iowa	Phase 4
Completed	Impulsivity in Pathological Gambling NCT00580567	University of California, Los Angeles	—
Completed	Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling NCT00438776	Lindner Center of HOPE	Phase 3
Completed	Cognitive Behavioral Therapy for Pathological Gambling NCT00337753	University of Minnesota	Phase 2
Completed	An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling NCT00273702	University of Minnesota	Phase 1
Terminated	Topiramate in the Treatment of Pathological Gambling NCT00245583	Icahn School of Medicine at Mount Sinai	Phase 3
Completed	Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling NCT00132119	Somaxon Pharmaceuticals	Phase 2 / Phase 3
Terminated	Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Di NCT00211822	Icahn School of Medicine at Mount Sinai	—
Completed	Effects of Internet-based Treatment of Pathological Gambling NCT01381250	Umeå University	N/A
Completed	Indicated Prevention With At-Risk Gamblers NCT00078273	University of Washington	Phase 2
Completed	Minimal and Brief Treatments for Pathological Gamblers NCT00203645	University of Calgary	Phase 3
Completed	Bupropion in the Treatment of Pathological Gambling NCT00055393	University of Iowa	N/A
Unknown	Descriptive Study of a French Sample of "at Risk" and Pathological Gamblers Followed in a French Structure Spe NCT00360321	Nantes University Hospital	—